In-silico studies on potential inhibitors of SARS-CoV2

The emergence of the SARS-CoV-2 virus, responsible for the COVID-19 pandemic, has spurred extensive research to identify effective treatments and preventative measures. One promising avenue is the repurposing of existing anti-malarial and anti-viral compounds, which have shown potential through molecular docking studies. These studies provide crucial insights into how these compounds interact with viral proteins and can aid in the development of novel therapies. In this article, authors will delve into the world of molecular docking studies concerning anti-malarial and anti-viral compounds for SARS-CoV-2.